Cargando…

The Role of Anticoagulation Clinics in the Era of New Oral Anticoagulants

Anticoagulation Clinics (ACs) are services specialized in management of patients on anticoagulant treatment. At present, ACs manage patients chiefly on antivitamin K antagonists (AVKs), but patient population has already changed in the last few years, because of an increase of treatments with other...

Descripción completa

Detalles Bibliográficos
Autores principales:	Testa, Sophie, Paoletti, Oriana, Zimmermann, Anke, Bassi, Laura, Zambelli, Silvia, Cancellieri, Emilia
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi Publishing Corporation 2012
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3477769/ https://www.ncbi.nlm.nih.gov/pubmed/23097696 http://dx.doi.org/10.1155/2012/835356

Ejemplares similares

Switch from oral anticoagulants to parenteral heparin in SARS-CoV-2 hospitalized patients
por: Testa, Sophie, et al.
Publicado: (2020)

Geographic Variations in the Quality of Oral Anticoagulation With Vitamin K Antagonists in the Era of New Anticoagulants
por: Fauchier, Laurent, et al.
Publicado: (2013)

Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants
por: Testa, Sophie, et al.
Publicado: (2019)

Factors associated with prescription of oral anticoagulants in the era of direct oral anticoagulants
por: Kataoka, Naoya, et al.
Publicado: (2023)

The new era of anticoagulation
por: Anklesaria, Zafia, et al.
Publicado: (2016)

Newer Oral Anticoagulant Agents: A New Era in Medicine
por: Goel, Ramil, et al.
Publicado: (2012)

Inherited Thrombophilia in the Era of Direct Oral Anticoagulants
por: Khider, Lina, et al.
Publicado: (2022)

Compliance and adherence to oral anticoagulation therapy in elderly patients with atrial fibrillation in the era of direct oral anticoagulants
por: Garkina, Svetlana V, et al.
Publicado: (2016)

Target-Specific Oral Anticoagulants—New Approaches in the Field of Oral Anticoagulation
por: Mani, Helen, et al.
Publicado: (2015)

New horizons in anticoagulation: Direct oral anticoagulants and their implications in oral surgery
por: Serrano-Sánchez, Víctor, et al.
Publicado: (2017)

Use of New Oral Anticoagulants / Direct Oral Anticoagulants in Malignant Patients
por: Khan, Yusra, et al.
Publicado: (2020)

Considerations for long-term anticoagulant therapy in patients with venous thromboembolism in the novel oral anticoagulant era
por: Toth, Peter P
Publicado: (2016)

VKORC1 and CYP2C9 polymorphisms related to adverse events in case-control cohort of anticoagulated patients
por: Misasi, Silvia, et al.
Publicado: (2016)

The role of oral anticoagulants in epistaxis
por: Buchberger, A. M. S., et al.
Publicado: (2018)

Lupus anticoagulant testing during anticoagulation, including direct oral anticoagulants
por: Favaloro, Emmanuel J., et al.
Publicado: (2022)

Warfarin or non-Vitamin K antagonist oral anticoagulants: Navigating the choice of oral anticoagulant drugs in the COVID-19 pandemic era
por: Heng, Cai, et al.
Publicado: (2020)

Evidence Gaps in the Era of Non–Vitamin K Oral Anticoagulants
por: Aronis, Konstantinos N., et al.
Publicado: (2018)

Results expression for tests used to measure the anticoagulant effect of new oral anticoagulants
por: Tripodi, Armando
Publicado: (2013)

Managing anticoagulation in the COVID-19 era between lockdown and reopening phases
por: Poli, Daniela, et al.
Publicado: (2020)

The proof for new oral anticoagulants: clinical trial evidence
por: Huisman, Menno V.
Publicado: (2011)

Expanding use of new oral anticoagulants
por: Weitz, Jeffrey I.
Publicado: (2014)

“A Tale of Two Cities”: Anticoagulation Management in Patients with Atrial Fibrillation and Prosthetic Valves in the Era of Direct Oral Anticoagulants
por: Palmiero, Giuseppe, et al.
Publicado: (2019)

Decision of Anticoagulation in Nonvalvular Atrial Fibrillation in the Real World in the Non-Antivitamin K Anticoagulants Era
por: Gheorghe, Gabriela Silvia, et al.
Publicado: (2022)

Anticoagulation in Patients Aged ≥75 years with Atrial Fibrillation: Role of Novel Oral Anticoagulants
por: Ng, Kuan H., et al.
Publicado: (2013)

Reversing anticoagulant effects of novel oral anticoagulants: role of ciraparantag, andexanet alfa, and idarucizumab
por: Hu, Tiffany Y, et al.
Publicado: (2016)

Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants
por: Weitz, Jeffrey I., et al.
Publicado: (2017)

The temporal context of oral anticoagulation outcome in atrial fibrillation
por: Fender, Anke C., et al.
Publicado: (2022)

Anticoagulation in difficult settings RELOADed: Evidence for applicability of direct oral anticoagulants in patients with atrial fibrillation, renal impairment and cancer
por: Fender, Anke C., et al.
Publicado: (2019)

Tailored Direct Oral Anticoagulation in Patients with Atrial Fibrillation: The Future of Oral Anticoagulation?
por: Samoš, Matej, et al.
Publicado: (2022)

The role of direct oral anticoagulants in the era of COVID-19: are antiviral therapy and pharmacogenetics limiting factors?
por: Roguljić, Hrvoje, et al.
Publicado: (2022)

The new oral anticoagulants in atrial fibrillation: an update
por: Verheugt, F. W. A.
Publicado: (2013)

Beyond warfarin: The advent of new oral anticoagulants
por: Laroia, Sandeep T, et al.
Publicado: (2015)

New oral anticoagulants – a practical guide
por: Ciurus, Tomasz, et al.
Publicado: (2015)

Beyond warfarin: The advent of new oral anticoagulants
por: Malhotra, Konark, et al.
Publicado: (2016)

Coagulation assessment with the new generation of oral anticoagulants
por: Pollack, Charles V
Publicado: (2016)

Continuation Versus Interruption of Direct Oral Anticoagulants for CIED Procedures: New Anticoagulants, Old Dilemma
por: Tonko, Johanna B., et al.
Publicado: (2021)

The Role of the Pharmacist in the Anticoagulant Clinic
por: Pegg, M., et al.
Publicado: (1985)

Traditional Anticoagulants and Hair Loss: A Role for Direct Oral Anticoagulants? A Review of the Literature
por: Watras, Magdalena M., et al.
Publicado: (2016)

Adherence to oral anticoagulant therapy in secondary stroke prevention – impact of the novel oral anticoagulants
por: Luger, Sebastian, et al.
Publicado: (2015)

Operative survival in patients with acute aortic disease in the era of newer oral anticoagulants
por: Bjørnstad, Johannes Lagethon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_d1qji43a9pms3ouem4n6834pmg